- ►nih.gov - Free from Publisher UHM Spandau, M Derse, P Schmitz- … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Methods: The prospective, randomised, double masked, clinical interventional
study included 27 eyes (27 patients) with diffuse diabetic macular oedema. They
were randomly divided into three study groups receiving an intravitreal ... Cited by 59 - Related articles - BL Direct - All 10 versions
- ►bmj.com [PDF] JB Jonas, I Akkoyun, I Kreissig, RF Degenring - British Medical Journal, 2005 - bjo.bmj.com Diffuse diabetic macular oedema treated by intravitreal ... JB Jonas, I
Akkoyun, I Kreissig, RF Degenring ..............................................
............................................................................ ... Cited by 55 - Related articles - All 8 versions
JB Jonas - Ophthalmic Res, 2006 - content.karger.com Background: Based on experimental studies and clinical observations by Robert
Machemer, Gholam Peyman and others, the vitreous cavity has increasingly been
used as a reservoir of drugs for the direct treatment of intraocular ... Cited by 46 - Related articles - BL Direct - All 5 versions
JB Jonas, BA Kamppeter, B Harder, U … - Journal of Ocular Pharmacology & Therapeutics, 2006 - liebertonline.com Purpose: The aim of this study was to examine the visual outcome of patients
receiving an intravitreal injection of triamcinolone acetonide (TA) as treatment
of diffuse diabetic macu- lar edema (DDME). Methods: This prospective, ... Cited by 31 - Related articles - BL Direct - All 4 versions
JB Jonas, P Martus, RF Degenring, I Kreissig, … - Archives of Ophthalmology, 2005 - Am Med Assoc Results In a multiple linear regression analysis, maximum gain in best-corrected
visual acuity after the intravitreal injection of triamcinolone was
significantly (P < .001) and negatively correlated with an increased degree ... Cited by 28 - Related articles - BL Direct - All 4 versions
JB Jonas, B Harder, BA Kamppeter - American journal of ophthalmology, 2004 - Elsevier In the study group, visual acuity increased significantly (P ≤ .001) by 3.0 ±
2.6 Snellen lines to a peak at two to six months after the injection, and
decreased significantly (P = .001) towards the end of follow up. At the end ... Cited by 26 - Related articles - All 13 versions
- ►nih.gov CKM Chan, S Mohamed, MP Shanmugam, CW … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Results: BCVA, CFT, intraocular pressure (IOP), and cataract scores were not
significantly different before initial and repeat injections (given at 32.5 (SD
3.5) weeks after the first injection). Transient improvements of BCVA and ... Cited by 24 - Related articles - BL Direct - All 8 versions
JB Jonas, UH Spandau, BA Kamppeter, U … - Ophthalmology, 2006 - Elsevier The investigation included a study group (the responders) of 19 patients (22
eyes) with diffuse diabetic macular edema, who showed an improvement in visual
acuity after an intravitreal injection of approximately 20 mg triamcinolone ... Cited by 23 - Related articles - All 13 versions
J Jonas - Developments in Ophthalmology, 2007 - content.karger.com Abstract Intravitreal triamcinolone acetonide (IVTA) has been applied in
exponentially increas- ing frequency for various intraocular neovascular and
edematous diseases, including diabetic macular edema, proliferating ... Cited by 21 - Related articles - BL Direct - All 5 versions
